Dienogest in endometriosis treatment: A narrative literature review
Open Access
- 1 December 2023
- journal article
- review article
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
- Vol. 50 (4) , 223-229
Abstract
Endometriosis is characterized by the implantation of endometrial cells outside the uterus. This hormone-dependent disease is highly prevalent among women of reproductive age. Clinical symptoms of endometriosis include dysmenorrhea, pelvic pain, and infertility, which can negatively impact the overall quality of life of those affected. The medical treatment of endometriosis serves as an important therapeutic option, aimed at alleviating pain associated with the condition and suppressing the growth of endometriotic lesions. As such, it is employed as an adjuvant therapy following surgery or an empirical treatment after the clinical diagnosis of endometriosis. Dienogest, a fourth-generation progestin, has received approval for the treatment of endometriosis in many countries. A growing body of evidence has demonstrated its efficacy in managing endometriosis-associated pain, preventing symptoms, and reducing lesion recurrence. In this review, we examine the clinical efficacy, safety, and tolerability of dienogest in treating endometriosis. We also provide updated findings, drawing from clinical studies that focus on the long-term use of this medication in patients with endometriosis.Keywords
This publication has 54 references indexed in Scilit:
- Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy WomenThe Journal of Clinical Pharmacology, 2012
- Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatmentArchives of Gynecology and Obstetrics, 2011
- Circulating Endothelial Progenitor Cells Are Up-Regulated in a Mouse Model of EndometriosisThe American Journal of Pathology, 2011
- Endometriosis and infertilityJournal of Assisted Reproduction and Genetics, 2010
- Endometriosis: New concepts in the pathogenesisThe International Journal of Biochemistry & Cell Biology, 2010
- Long‐term use of dienogest for the treatment of endometriosisJournal of Obstetrics and Gynaecology Research, 2009
- A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosisInternational Journal of Gynecology & Obstetrics, 2009
- Safety of dienogest in the long-term treatment of endometriosis: a one-year, open-label, follow-up studyFertility and Sterility, 2009
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profileSteroids, 2008
- DienogestDrugs, 1998